EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma

• Baoping Guo ,

  Contributed equally to this work with: Baoping Guo, Xiaohong Tan

  Roles Data curation, Formal analysis, Methodology, Software, Writing – original draft

  Affiliation Department of Chemotherapy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China

  ⨯
• Xiaohong Tan ,

  Contributed equally to this work with: Baoping Guo, Xiaohong Tan

  Roles Funding acquisition, Project administration, Writing – review & editing

  Affiliation Department of Chemotherapy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China

  ⨯
• Hong Cen

  Roles Funding acquisition, Project administration, Writing – review & editing

  * E-mail: cenhong981@gxmu.edu.cn

  Affiliation Department of Chemotherapy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China

  https://orcid.org/0000-0002-2883-7123

  ⨯